Marie Sanchirico

4PUBLICATIONS
6CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Deep learningImmunogenetics (incl. genetic immunology)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 01, 2026
A real-world observational study of second-line anti-TNFα treatment in patients with ulcerative colitis who received vedolizumab as a first-line biologic.

|Sep 23, 2024
Machine-Learning Model Identifies Patients With Alpha-1 Antitrypsin Deficiency Using Claims Records.

Rajani Sharma, D Kyle Hogarth, Richard Colbaugh

|Jun 17, 2024
Initiating immunoglobulin replacement therapy helps reduce severe infections and shifts healthcare resource utilization to outpatient services among US patients with inborn errors of immunity.

Faisal Riaz, Kandavadivu Umashankar, Elizabeth Hoit Marchlewicz

|Feb 22, 2023
Real-World Evidence of Tolerability of 20% Subcutaneous Immunoglobulin Treatment.

Kevin Rosenbach, Michelle Park, Marie Sanchirico

Pageof 1

Frequent Collaborators

1 joint publications

Faisal Riaz

1 joint publications

Kandavadivu Umashankar

1 joint publications

Elizabeth Hoit Marchlewicz

1 joint publications

Nikhil Khandelwal